| Adjusted for midazolam dose (model 1) | Adjusted for RASS* (model 2) | ||
---|---|---|---|---|
Variables | AdjOR, 95% CI | p value | AdjOR, 95%-CI | p value |
∆HR [bpm] | 0.96, 0.94–0.98 | < 0.001 | 0.95, 0.93–0.98 | < 0.001 |
Age [years] | 1.06, 1.05–1.07 | < 0.001 | 1.06, 1.05–1.07 | < 0.001 |
H&H grade | 1.86, 1.65–2.09 | < 0.001 | 1.95, 1.72–2.22 | < 0.001 |
Absolute HR [bpm] | 1.02, 1.01–1.03 | 0.003 | 1.02, 1.01–1.03 | < 0.001 |
Daily cumulative dobutamine dose [mg] | 0.998, 0.997–0.999 | 0.001 | 0.998, 0.997–0.999 | < 0.001 |
Daily cumulative noradrenaline dose [mg] | 0.99, 0.98–1.00 | 0.173 | 0.99, 0.97–0.998 | 0.028 |
Daily cumulative sufentanil dose [μg] | 1.00, 1.00–1.00 | 0.074 | 1.00, 1.00–1.00 | 0.037 |
Daily cumulative midazolam dose [mg] | 1.00, 0.99–1.00 | 0.344 | – | – |
RASS | – | – | 0.70, 0.50–0.98 | 0.040 |